miR‑342‑3p suppresses cell migration and invasion in preeclampsia by targeting platelet‑derived growth factor receptor α

Yang,Xiuhua; Guo,Feng

doi:10.3892/mmr.2019.10372

miR‑342‑3p suppresses cell migration and invasion in preeclampsia by targeting platelet‑derived growth factor receptor α

Authors:
- Xiuhua Yang
- Feng Guo
View Affiliations

Affiliations: Department of Obstetrics, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Department of Emergency, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
Published online on: June 10, 2019 https://doi.org/10.3892/mmr.2019.10372
Pages: 1772-1780
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

miR‑342‑3p expression was increased in the placentas of women with preeclampsia (PE) according to previous examinations; the mechanism underlying the development and progression of PE requires further investigation. The present study aimed to explore the mechanism and functionality of microRNA (miR)‑342‑3p in trophoblastic cells. The expression of miR‑342‑3p and platelet‑derived growth factor receptor α (PDGFRA) in the placentas of 30 patients with PE and 30 normal controls was detected. In addition, HTR8/SVneo cells were transfected with miR‑342‑3p mimics, small interfering RNA (siR)‑PDGFRA or their corresponding negative controls; then the proliferation, migration, invasion and the distribution of the cell cycle of these cells were analyzed. Additionally, a dual‑luciferase reporter assay was performed. According to these analyses, the expression of miR‑342‑3p was significantly increased, while that of PDGFRA was significantly lower in the PE group compared with the normal group. Transfection with miR‑342‑3p mimics led to a significant decrease in cell proliferation, migration and invasion, and also affected the cell cycle. Furthermore, miR‑342‑3p mimics reduced the expression of PDGFRA; miR‑342‑3p overexpression also reduced the mRNA and protein levels of BCL‑2 and Caspase‑3. In addition, transfection of siR‑PDGFRA exhibited similar effects to those of miR‑342‑3p mimics. Finally, PDGFRA was reported to be a direct target of miR‑342‑3p. In conclusion, miR‑342‑3p was proposed to inhibit the proliferation, migration, invasion and G1/S phase transition of HTR8/SVneo cells by suppressing PDGFRA. Our findings suggest that miR‑342‑3p may be a novel clinical indicator or prognostic marker for PE.

View Figures

View References

1	Cheung HC, Leung KY and Choi CH: Diagnostic accuracy of spot urine protein-to-creatinine ratio for proteinuria and its association with adverse pregnancy outcomes in Chinese pregnant patients with pre-eclampsia. Hong Kong Med J. 22:249–255. 2016.PubMed/NCBI
2	Askie LM, Duley L, Henderson-Smart DJ and Stewart LA; PARIS Collaborative Group, : Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet. 369:1791–1798. 2007. View Article : Google Scholar : PubMed/NCBI
3	Turner RJ, Bloemenkamp KW, Bruijn JA and Baelde HJ: Loss of thrombomodulin in placental dysfunction in preeclampsia. Arterioscler Thromb Vasc Biol. 36:728–735. 2016. View Article : Google Scholar : PubMed/NCBI
4	Hastie R, Brownfoot FC, Pritchard N, Hannan NJ, Cannon P, Nguyen V, Palmer K, Beard S, Tong S and Kaitu'u-Lino TJ: EGFR (epidermal growth factor receptor) signaling and the mitochondria regulate sFlt-1 (soluble FMS-like tyrosine kinase-1) secretion. Hypertension. 73:659–670. 2019. View Article : Google Scholar : PubMed/NCBI
5	Yang X and Meng T: MicroRNA-431 affects trophoblast migration and invasion by targeting ZEB1 in preeclampsia. Gene. 683:225–232. 2019. View Article : Google Scholar : PubMed/NCBI
6	Liang T, Hu XY, Li YH, Tian BQ, Li ZW and Fu Q: MicroRNA-21 regulates the proliferation, differentiation, and apoptosis of human renal cell carcinoma cells by the mTOR-STAT3 signaling pathway. Oncol Res. 24:371–380. 2016. View Article : Google Scholar : PubMed/NCBI
7	Liu M, Chen Y, Song G, Chen B, Wang L, Li X, Kong X, Shen Y and Qian L: MicroRNA-29c overexpression inhibits proliferation and promotes apoptosis and differentiation in P19 embryonal carcinoma cells. Gene. 576:304–311. 2016. View Article : Google Scholar : PubMed/NCBI
8	Zhou N, Fei D, Zong S, Zhang M and Yue Y: MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer. Oncol Lett. 12:3633–3639. 2016. View Article : Google Scholar : PubMed/NCBI
9	Yang X, Lei P, Huang Y, Zhang Z and Zhang Y: MicroRNA-133b inhibits the migration and invasion of non-small cell lung cancer cells via targeting FSCN1. Oncol Lett. 12:3619–3625. 2016. View Article : Google Scholar : PubMed/NCBI
10	Zhao G, Zhou X, Chen S, Miao H, Fan H, Wang Z, Hu Y and Hou Y: Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia. J Biomed Sci. 21:812014. View Article : Google Scholar : PubMed/NCBI
11	Biró O, Nagy B and Rigó J Jr: Identifying miRNA regulatory mechanisms in preeclampsia by systems biology approaches. Hypertens Pregnancy. 36:90–99. 2017. View Article : Google Scholar : PubMed/NCBI
12	Yang S, Li H, Ge Q, Guo L and Chen F: Deregulated microRNA species in the plasma and placenta of patients with preeclampsia. Mol Med Rep. 12:527–534. 2015. View Article : Google Scholar : PubMed/NCBI
13	Li H, Ge Q, Guo L and Lu Z: Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed Res Int. 2013:9702652013. View Article : Google Scholar : PubMed/NCBI
14	Hromadnikova I, Kotlabova K, Ivankova K, Vedmetskaya Y and Krofta L: Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction. Int J Cardiol. 249:402–409. 2017. View Article : Google Scholar : PubMed/NCBI
15	Choi SY, Yun J, Lee OJ, Han HS, Yeo MK, Lee MA and Suh KS: MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta. 34:799–804. 2013. View Article : Google Scholar : PubMed/NCBI
16	Li XR, Chu HJ, Lv T, Wang L, Kong SF and Dai SZ: miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer. FEBS Lett. 588:3298–3307. 2014. View Article : Google Scholar : PubMed/NCBI
17	Xie X, Liu H, Wang M, Ding F, Xiao H, Hu F, Hu R and Mei J: miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells. Tumour Biol. 36:5031–5038. 2015. View Article : Google Scholar : PubMed/NCBI
18	Zhao L and Zhang Y: miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. Biochem Biophys Res Commun. 457:370–377. 2015. View Article : Google Scholar : PubMed/NCBI
19	Jarvenpaa J, Vuoristo JT, Savolainen ER, Ukkola O, Vaskivuo T and Ryynanen M: Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction. Gynecol Endocrinol. 23:351–355. 2007. View Article : Google Scholar : PubMed/NCBI
20	Saito T and Saetrom P: MicroRNAs-targeting and target prediction. N Biotechnol. 27:243–249. 2010. View Article : Google Scholar : PubMed/NCBI
21	Zhang C, Li Q, Ren N, Li C, Wang X, Xie M, Gao Z, Pan Z, Zhao C, Ren C and Yang W: Placental miR-106a~363 cluster is dysregulated in preeclamptic placenta. Placenta. 36:250–252. 2015. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Schatz F, Guzeloglu-Kayisli O, Arlier S, Kayisli UA and Lockwood CJ: The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancyoutcomes and abnormal uterine bleeding. Hum Reprod Update. 22:497–515. 2016. View Article : Google Scholar : PubMed/NCBI
24	Redline RW and Patterson P: Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol. 26:594–600. 1995. View Article : Google Scholar : PubMed/NCBI
25	Ji L, Zhang L, Li Y, Guo L, Cao N, Bai Z, Song Y, Xu Z, Zhang J, Liu C and Ma X: MiR-136 contributes to pre-eclampsia through its effects on apoptosis and angiogenesis of mesenchymal stem cells. Placenta. 50:102–109. 2017. View Article : Google Scholar : PubMed/NCBI
26	Yang W, Wang A, Zhao C, Li Q, Pan Z, Han X, Zhang C, Wang G, Ji C, Wang G, et al: miR-125b enhances IL-8 production in earlyonset severe preeclampsia by targeting sphingosine-1-phosphate lyase 1. PLoS One. 11:e01669402016. View Article : Google Scholar : PubMed/NCBI
27	Ding GC, Chen M, Wang YX, Rui C, Xu W, Ding HJ and Shi ZH: MicroRNA-128a-induced apoptosis in HTR-8/SVneo trophoblast cells contributes to pre-eclampsia. Biomed Pharmacother. 81:63–70. 2016. View Article : Google Scholar : PubMed/NCBI
28	Wu H, Wang H, Liu M, Bai Y, Li YX, Ji L, Peng C, Yu Y and Wang YL: MiR-195 participates in the placental disorder of preeclampsia via targeting activin receptortype-2B in trophoblastic cell. J Hypertens. 34:1371–1379. 2016. View Article : Google Scholar : PubMed/NCBI
29	Hromadnikova I, Kotlabova K, Hympanova L and Krofta L: Cardiovascular and cerebrovascular disease associated microRNAs are dysregulated in placental tissues affected with gestational hypertension, preeclampsia and intrauterine growth restriction. PLoS One. 10:e01383832015. View Article : Google Scholar : PubMed/NCBI
30	Wu L, Zhou H, Lin H, Qi J, Zhu C, Gao Z and Wang H: Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction. 143:389–397. 2012. View Article : Google Scholar : PubMed/NCBI
31	Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H and Yu H: Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. Am J Transl Res. 6:391–401. 2014.PubMed/NCBI
32	Xue X, Fei X, Hou W, Zhang Y, Liu L and Hu R: miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. Cancer Lett. 412:170–178. 2017. View Article : Google Scholar : PubMed/NCBI
33	Zhang S, Liu L, Lv Z, Li Q, Gong W and Wu H: MicroRNA-342-3p inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting astrocyte-elevated gene-1 (AEG-1). Oncol Res. 25:1505–1515. 2017. View Article : Google Scholar : PubMed/NCBI
34	Huang H, Fan L, Zhan R, Wu S and Niu W: Expression of microRNA-10a, microRNA-342-3p and their predicted target gene TIAM1 in extranodal NK/T-cell lymphoma, nasal type. Oncol Lett. 11:345–351. 2016. View Article : Google Scholar : PubMed/NCBI
35	Tai MC, Kajino T, Nakatochi M, Arima C, Shimada Y, Suzuki M, Miyoshi H, Yatabe Y, Yanagisawa K and Takahashi T: miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis. 36:1464–1473. 2015.PubMed/NCBI
36	Wang L, Xu L, Xu M, Liu G, Xing J, Sun C and Ding H: Obesity-Associated miR-342-3p promotes adipogenesis of mesenchymal stem cells by suppressing CtBP2 and releasing C/EBPα from CtBP2 binding. Cell Physiol Biochem. 35:2285–2298. 2015. View Article : Google Scholar : PubMed/NCBI
37	Lan H, Chen W, He G and Yang S: miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. Biomed Pharmacother. 75:117–122. 2015. View Article : Google Scholar : PubMed/NCBI
38	Xu H, Han Y, Lou J, Zhang H, Zhao Y, Győrffy B and Li R: PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer. Oncotarget. 8:69520–69526. 2017.PubMed/NCBI
39	Kalfusová A and Kodet R: Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs. Cesk Patol Winter. 53:167–173. 2017.(In Czech).
40	Bai X, Kong Y, Chi Z, Sheng X, Cui C, Wang X, Mao L, Tang B, Li S, Lian B, et al: MAPK pathway and TERT promoter gene mutation pattern and its prognostic value in melanoma patients: A retrospective study of 2,793 cases. Clin Cancer Res. 23:6120–6127. 2017. View Article : Google Scholar : PubMed/NCBI
41	Chen W, Kuang Y, Qiu HB, Cao Z, Tu Y, Sheng Q, Eilers G, He Q, Li HL, Zhu M, et al: Dual targeting of insulin receptor and KIT in imatinib-resistant gastrointestinal stromal tumors. Cancer Res. 77:5107–5117. 2017. View Article : Google Scholar : PubMed/NCBI